Back to Journals » International Journal of Nephrology and Renovascular Disease » Volume 3

Polycystic kidney disease: inheritance, pathophysiology, prognosis, and treatment

Authors Halvorson CR, Bremmer M, Jacobs SC

Published 24 June 2010 Volume 2010:3 Pages 69—83

DOI https://doi.org/10.2147/IJNRD.S6939

Review by Single-blind

Peer reviewer comments 4


Christian R Halvorson1, Matthew S Bremmer1, Stephen C Jacobs1

1Department of Surgery, University of Maryland School of Medicine, Baltimore, MD, USA

Abstract: Both autosomal dominant and recessive polycystic kidney disease are conditions with severe associated morbidity and mortality. Recent advances in the understanding of the genetic and molecular pathogenesis of both ADPKD and ARPKD have resulted in new, targeted therapies designed to disrupt cell signaling pathways responsible for the abnormal cell proliferation, dedifferentiation, apoptosis, and fluid secretion characteristic of the disease. Herein we review the current understanding of the pathophysiology of these conditions, as well as the current treatments derived from our understanding of the mechanisms of these diseases.

Keywords: Polycystic kidney disease, autosomal dominant, recessive, end stage renal disease

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]